Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope.

Collapse authors list.
Md Yusof, Md Yuzaiful, Smith, Eve MD ORCID: 0000-0002-8371-7597, Ainsworth, Sammy, Armon, Kate, Beresford, Michael W, Brown, Morgan, Cherry, Lindsey, Edwards, Christopher J, Flora, Kalveer, Gilman, Rebecca et al (show 25 more authors) , Griffiths, Bridget, Gordon, Caroline, Howard, Paul, Isenberg, David, Jordan, Natasha, Kaul, Arvind, Lanyon, Peter, Laws, Philip M, Lightsone, Liz, Lythgoe, Hanna, Mallen, Christian D, Marks, Stephen D, Maxwell, Naomi, Moraitis, Elena, Nash, Clare, Pepper, Ruth J, Pilkington, Clarissa, Psarras, Antonios, Rostron, Heather, Skeates, Jade, Skeoch, Sarah, Tremarias, Dalila, Wincup, Chris, Zoma, Asad and Vital, Edward M (2023) Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope. Rheumatology advances in practice, 7 (3). rkad093-rkad093.

Access the full-text of this item by clicking on the Open Access link.

Abstract

The objective of this guideline is to provide up-to-date, evidence-based recommendations for the management of SLE that builds upon the existing treatment guideline for adults living with SLE published in 2017. This will incorporate advances in the assessment, diagnosis, monitoring, non-pharmacological and pharmacological management of SLE. General approaches to management as well as organ-specific treatment, including lupus nephritis and cutaneous lupus, will be covered. This will be the first guideline in SLE using a whole life course approach from childhood through adolescence and adulthood. The guideline will be developed with people with SLE as an important target audience in addition to healthcare professionals. It will include guidance related to emerging approved therapies and account for National Institute for Health and Care Excellence Technology Appraisals, National Health Service England clinical commissioning policies and national guidance relevant to SLE. The guideline will be developed using the methods and rigorous processes outlined in 'Creating Clinical Guidelines: Our Protocol' by the British Society for Rheumatology.

Item Type:	Article
Uncontrolled Keywords:	biologic DMARDs, guideline, lupus nephritis, management, systemic lupus erythematosus
Divisions:	Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User:	Symplectic Admin
Date Deposited:	12 Mar 2024 08:40
Last Modified:	12 Mar 2024 10:45
DOI:	10.1093/rap/rkad093
Open Access URL:	https://doi.org/10.1093/rap/rkad093
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3179266